Jump to Main Contents
ncc en

Home > Information


Apr. 12, 2022
Hiroyoshi Nishikawa honored with a prestigious Commendation from the Minister of Education, Culture, Sports, Science and Technology
Mar. 25, 2022
Franco-Japanese immuno-oncology webinar 2st session held
Mar. 18, 2022
Aberrant activation of cell cycle-related kinases in uterine leiomyosarcoma
Mar. 3, 2022
Discovery of splicing vulnerability and novel therapy in RAS Q61 cancers -Nature-
Feb. 21, 2022
Memorandum of Understanding signed with Peking University First Hospital
Feb. 1, 2022
Recruitment of Postdoctoral Fellow
Feb. 1, 2022
Virtual Meeting with Tata Memorial Centre of India, Celebrating the Conclusion of Memorandum of Understanding
Jan. 28, 2022
Franco-Japanese immuno-oncology webinar 1st session held
Jan. 28, 2022
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments
Jan. 18, 2022
Tatsuhiro Shibata awarded Princess Takamatsu Cancer Research Fund Prize
Jan. 11, 2022
Joint Statement Announced upon the visit by Prime Minister of Viet Nam
Jan. 6, 2022
Franco-Japanese immuno-oncology webinar series
Dec. 24, 2021
Depletion of central memory CD8+T cells might impede the antitumor therapeutic effect of Mogamulizumab
Dec. 23, 2021
Webinar for “Russo -Japanese Joint Symposium”
Dec. 23, 2021
Launch of an Asian international collaborative prospective study on 6 advanced cancers common in Asia
Dec. 21, 2021
CLIP1-LTK fusion: A novel druggable gene fusion in NSCLC,
identified using LC-SCRUM-Asia genomic screening platform
Dec. 14, 2021
Endoscopists at the National Cancer Center Hospital selected as world-class experts in endoscopic mucosal resection (EMR) by Expertscape
Dec. 1, 2021
Joint Statement Issued with National Cancer Hospital, Viet Nam
Nov. 22, 2021
Memorandum of Understanding signed with Frederick National Laboratory for Cancer Research
Nov. 15, 2021
Activated WNT/β-catenin pathway induces resistance to immunotherapies in cancers harboring high tumor mutation burden
Nov. 12, 2021
Study shows efficacy of dual-HER2 targeted therapy for patients with HER2-positive colorectal cancer
Nov. 11, 2021
First in-patient transplantation of iPS cell-derived natural killer cells to treat ovarian cancer
Oct. 28, 2021
Unveiling the Landscape of Genomic Alterations in Adult T-Cell Leukemia/Lymphoma
Oct. 27, 2021
Global whole genome sequencing research on esophageal cancers reveals
carcinogenic mechanisms specific to Japan
Oct. 27, 2021
For future collaboration of Japan-China-Korea NCCs
Oct. 20, 2021
Oct. 14, 2021
Breakthrough Discovery on the Structure and Activation Mechanism of ALK
Oct. 7, 2021
National Cancer Center Hospital on Newsweek’s “World’s Best Specialized Hospitals 2022 (Oncology)”
Sep. 8, 2021
Shun-ichi Watanabe awarded the Ginsberg Lectureship Award for Surgery at the 2021 World Conference on Lung Cancer
Sep. 6, 2021
Molecular landscape of multi-step virus carcinogenesis revealed by multi-modal single-cell analysis
Aug. 17, 2021
Whole Genome Sequencing Finds Therapeutic Targets for Linitis Plastica-type Gastric Cancer
Aug. 16, 2021
Webinar with Neijiang, China
Jul. 20, 2021
Japan-China-Korea NCCs Top Meeting
Jun. 30, 2021
Initiation of the 4th-stage industry-academia collaborative Cancer Genome Screening Project for Individualized Medicine in Japan, SCRUM-Japan
Jun. 22, 2021
Webinar with the Fourth Hospital of Hebei Medical University
Jun. 14, 2021
Visit by Young Leaders’ Program from Nagoya University
Jun. 2, 2021
SARS-CoV-2 antibody status in patients with cancer during the COVID-19 pandemic in Japan
May 27, 2021
MOU concluded with Thai Society of Clinical Oncology (TSCO)
May 17, 2021
"MONSTAR-SCREEN" has joined as an official member program in the International Cancer Genome Consortium Accelerating Research in Genomic Oncology (ICGC-ARGO)
May 14, 2021
Apr. 27, 2021
National Cancer Center Japan and Pharmaceuticals and Medical Devices Agency Endorsed as a joint Center of Excellence by APEC
Apr. 23, 2021
Cancer Statistics in Japan; Table download
Apr. 9, 2021
Dr Hiroyuki Mano was awarded the 49th Fondation ARC Leopold Griffuel Prize for Clinical and Translational Cancer Research
Mar. 23, 2021
First drug approved for unresectable thymic carcinoma
Feb. 15, 2021
NCC Leadership Courtesy Visit to His Excellency the Ambassador of France
Feb. 2, 2021
Deep Vision: Near-Infrared Imaging and Machine Learning Can Identify Hidden Tumors
Dec. 25, 2020
Japan-China-Korea ASEAN
Cancer Registration and Cancer Control Course
Dec. 25, 2020
Three Researchers from National Cancer Center on “Highly Cited Researchers 2020” List
Dec. 20, 2020
Construction Begins on the“Kashiwa-no-ha Hotel Project (tentative name)”to Create a New Clinical Model in Kashiwa-no-ha
Nov. 27, 2020
Royal Thai Embassy HE Ambassador Mr Singtong Lapisatepun Visit
Nov. 25, 2020
Hiroyoshi Nishikawa Elected AAAS Fellow
Nov. 17, 2020
Hiroyoshi Nishikawa Honoured with the 2020 SITC ‘Team Science Award’
Nov. 13, 2020
Second ANCCA High Level Video Conference
Oct. 26, 2020
The 8th NCC-IARC Seminar on Childhood Cancer
Oct. 9, 2020
C/Can Digital Health Discovery Forum
Asia Regional Expert Dialogues
Oct. 6, 2020
Development of Precision Medicine for Gastrointestinal Cancers Utility of Liquid Biopsy in Genomic Analysis
Oct. 1, 2020
Japan-China-Korea Cancer Control Workshop
Sep. 11, 2020
MOU signed with Tianjin Medical University Cancer Institute & Hospital
Sep. 9, 2020
Asian early phase drug development network
ATLAS Project – Paving the way towards developing drugs with Asian partners
Sep. 1, 2020
A novel biomarker for predicting clinical efficacy of PD-1 blockade therapies
Aug. 28, 2020
MOU signed with Ho Chi Minh City Oncology Hospital(HCMCOH)in Vietnam
Aug. 20, 2020
NCC joins GSK’s oncology development network
Jul. 3, 2020
The National Cancer Center, the National Center for Global Health and Medicine, and Sysmex Corporation Evaluate a SARS-CoV-2 Antibody Test with Support from the Japan Health Research Promotion Bureau
Jun. 22, 2020
National Cancer Center Japan and Mitsui Fudosan Agree on Accommodation Facility at the National Cancer Center Hospital East in Kashiwa-no-ha Smart City
Jun. 11, 2020
Dr. Manami Inoue nominated Scientific Council Member of IARC
Apr. 28, 2020
Japan-China-Korea National Cancer Centers
Covid-19 Infection Control Meeting
Apr. 9, 2020
Novel oncogenic mechanism identified through a comprehensive pan-cancer genomic study
-application in cancer precision medicine anticipated-
Apr. 1, 2020
Advanced Medical Care Approval for Cancer Gene Panel Testing at the Time of Initial Treatment
- Prospective Study to Assess the Feasibility and Clinical Utility of Comprehensive Genomic Profiling at the Time of Initial Treatment of Patients with Solid Tumors -
Mar. 24, 2020
coronavirus outbreak response update
Mar. 17, 2020
Notice in response to coronavirus outbreak
Mar. 2, 2020
HE Professor Tomasz Grodzki, Polish Senate Marshal visit
Feb. 26, 2020
WHO and IARC Cancer Reports Published
Feb. 20, 2020
Franco-Japanese Pediatric Cancers Workshop
Feb. 17, 2020
Global Consortium Completes Tumor Analyses Project
Feb. 10, 2020
Cancer Registration Training in Lao PDR
Jan. 31, 2020
In due respect to global efforts to contain the spread of new coronavirus, the National Cancer Center of Japan requests your kind cooperation for the welfare of our patients.
Jan. 29, 2020
Clinical Trial Investigators visit NCC Hospital
Jan. 24, 2020
IAEA workshop at NCC
Dec. 16, 2019
ANCCA High Level video conference and Website GoLive
Dec. 11, 2019
Test Result of New Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting Proves Higher Efficacy Than Standard Antiemetic Therapy
Nov. 8, 2019
Quality Control Training for Cancer Registry in Myanmar
Nov. 7, 2019
Commencement of Clinical Trial of Boron Neutron Capture Therapy (BNCT) for Malignant Melanoma and Angiosarcoma
Sep. 30, 2019
Cancer Registration Training in Vietnam
Aug. 16, 2019
Proposed Operational Plan and Recommendations for Cancer Registration in Myanmar
Aug. 13, 2019
Cancer Statistics in Japan; Table download
May 29, 2019
Cancer Gene Panel Test OncoGuideTM NCC Oncopanel System added to Health Insurance Coverage list
May 23, 2019
New Memorandum of Understanding signed with Cancer Center at Beth Israel Deaconess Medical Center
Apr. 22, 2019
The Hon Mrs Carrie Lam, HKSAR Chief Executive visit
Apr. 16, 2019
Dr Yasuhiro Fujiwara hosted by National Cancer Center in Beijing
Mar. 28, 2019
National Cancer Center Japan and IARC’s Joint Seminar 6
Mar. 26, 2019
Launch a joint research project on a new cancer immunotherapy using liposome, a drug delivery system technology
-Goal is to identify its actions on immune cells, and elucidate the mechanism by which survival periods are extended-
Mar. 7, 2019
Kazakhstan Delegation visit
Feb. 12, 2019
UK Genomics Delegation visit
Jan. 23, 2019
National Cancer Center Japan and IARC’s Joint Seminar 5
Jan. 22, 2019
MoU (Memorandum of Understanding) signed with National Cancer Institute, Thailand
Jan. 22, 2019
Dr Kazuaki Shimada appointed Honorary Professor at Tianjin Medical University Cancer Institute and Hospital
Dec. 10, 2018
Asian National Cancer Centers Alliance (ANCCA) - 7th Meeting in Jakarta, Indonesia
Nov. 26, 2018
National Cancer Center Hospital offers Next Generation Sequencing tests as ‘Advanced Medical Care’ Towards coverage under national health insurance system
Nov. 19, 2018
Action across borders
Nov. 19, 2018
Quickening the pace of new anti-cancer agents Attracting nanoparticles full of cancer drugs to the stroma of a tumour is proving key to new therapeutics.
Nov. 13, 2018
Hospital East honoured at ESMO
Nov. 12, 2018
Facilitating International Clinical Trials Initiated by
Japanese Academic Institutions
Japan-led Global Investigator-Initiated Registration-Directed Trial of Advanced or Metastatic Breast Cancer (PATHWAY trial) Has Started
Oct. 12, 2018
Cancer Registration Training at Cambodia and Viet Nam
Oct. 1, 2018
National Cancer Center Japan and Maruho Enter License Agreement and Research Collaboration Agreement for a Novel Analgesic for Stomatitis in Cancer Treatment
Sep. 18, 2018
Visit to Norman E. Sharpless MD and his delegation at the National Cancer Institute
Sep. 15, 2018
Projected Cancer Statistics, 2018
Aug. 22, 2018
National Cancer Center Japan - IARC Seminar 4
Aug. 8, 2018
Dr Masaaki Ito appointed Honorary Professor at China-Japan Friendship Hospital
Aug. 2, 2018
Organization Chart Updated
Jun. 27, 2018
Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma
Jun. 1, 2018
NCC Establishes Center for Cancer Genomics and Advanced
Therapeutics (C-CAT) to Aggregate and Manage Information on
Cancer Genomic Medicine and Promote Its Use
May 28, 2018
New Agreement with National Cancer Hospital, Vietnam
May 7, 2018
National Cancer Center and Carna Biosciences Announce Research Collaboration for new drug discovery
Apr. 23, 2018
National Cancer Center – IARC Seminar 3
Apr. 3, 2018
National Cancer Center Hospital offers Next Generation Sequencing tests as ‘Advanced Medical Care’
Towards coverage under national health insurance system
Apr. 3, 2018
Advanced Medical Care Approval Received for Multiplex Gene Panel Testing
to Advancing Personalized Medicine
Mar. 30, 2018
NCC joins China and Korea at the first 3 national cancer centers’ workshop
Mar. 19, 2018
Cancer Registration Seminar in Indonesia
Mar. 13, 2018
SCRUM-Japan GI-SCREEN Aims for Realizing of Cancer Precision Medicine Utilizing Liquid Biopsy by Analyzing Comprehensive Cancer Genome Alterations in Blood
Mar. 9, 2018
WHO Classification of Tumours Series appoints Dr Ochiai to Editorial Board
Feb. 14, 2018
A secondary RET mutation in the activation loop conferring
resistance to vandetanib through allosteric effects
Feb. 5, 2018
Maestro Chung Visit
Jan. 23, 2018
Precise cancer risk estimation based upon measurement of mutations and aberrant DNA methylation accumulated in normal tissues
association between the accumulation and life style
Dec. 22, 2017
T. Matsuda takes office of International Association of Cancer Registries President
Dec. 18, 2017
Cancer Statistics in Japan; Table download
Dec. 14, 2017
National Cancer Center - IARC Seminar 2
Dec. 5, 2017
NCC signs comprehensive MoU with WHO/IARC
Nov. 27, 2017
Asian Early Phase Oncology Drug Development Consortium Formed
Nov. 21, 2017
New Agreement with National Cancer Center, Indonesia
Nov. 14, 2017
Lithuanian Health Minister Visit
Oct. 30, 2017
Cancer Statistics in Japan; Table download
Oct. 27, 2017
Collaborative Research on Fully-personalized Cancer Neoantigen Vaccine
Oct. 27, 2017
Projected Cancer Statistics, 2017
Oct. 26, 2017
National Cancer Center - IARC Seminar 1
Oct. 16, 2017
Commencement of Collaborative Research on Measurement of Exosomes in Blood from Cancer Patients
Aug. 3, 2017
Japan-Singapore lead international research in discovering potential targeted treatments for biliary tract cancer
Aug. 1, 2017
On-Table Adaptive Radiation Therapy
Jul. 31, 2017
Genomic medicine in Rare Cancers:
A collaboration between the industry and academia
Jul. 21, 2017
Cancer Registration Seminar in Myanmar
Jul. 11, 2017
Cancer Statistics in Japan; Table download(Link to Cancer Information Service)
Jun. 26, 2017
A novel biomarker for development of a new screening technique for early-stage pancreatic cancer and precancerous conditions associated with risk of pancreatic malignancy - experimental screening in Kagoshima Prefecture
Jun. 16, 2017
National Cancer Center hosts Iranian Delegation
May 30, 2017
WHO/International Agency for Research on Cancer establishes National Cancer Center as Global Initiative for Cancer Registry Development Collaborating Centre
Apr. 27, 2017
Elucidation of the mechanism of MLL-rearranged leukemia Use of two molecularly targeted drugs as novel therapy
Mar. 1, 2017
Commencement of Phase 1 Trial for the Mutant IDH1 Inhibitor (DS-1001)Targeting Malignant Brain Tumors
Feb. 28, 2017
Malignant extracellular vesicles derived from ovarian cancer cells facilitate peritoneal dissemination, and the vesicles can be promising targets for improving patient outcomes.
Feb. 21, 2017
Signing MOU with the National Cancer Research Institute (UK)